Sookaromdee, P., & Wiwanitkit, V. (2021). Change of safety interval from hyperviscosity problem in COVID-19 vaccine recipient with underlying diabetic problem. Wolters Kluwer Medknow Publications.
Cita Chicago Style (17a ed.)Sookaromdee, Pathum, y Viroj Wiwanitkit. Change of Safety Interval from Hyperviscosity Problem in COVID-19 Vaccine Recipient with Underlying Diabetic Problem. Wolters Kluwer Medknow Publications, 2021.
Cita MLA (8a ed.)Sookaromdee, Pathum, y Viroj Wiwanitkit. Change of Safety Interval from Hyperviscosity Problem in COVID-19 Vaccine Recipient with Underlying Diabetic Problem. Wolters Kluwer Medknow Publications, 2021.
Precaución: Estas citas no son 100% exactas.